High-fat diet associated with obesity induces impairment of mouse corpus cavernosum responses

BJU International

Volumn 107, Issue 10, 2011, Pages 1628-1634

  Toque, Haroldo A ^c   Da Silva, Fábio H ^a   Calixto, Marina C ^a   Lintomen, Letícia ^a   Schenka, André A ^a   Saad, Mario J ^a   Zanesco, Angelina ^b   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

cyclic GMP; endothelin 1; male impotence; nitric oxide; noradrenaline; obesity

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; ELECTROSTIMULATION; ENDOTHELIAL DYSFUNCTION; ENZYME IMMUNOASSAY; ERECTILE DYSFUNCTION; LIPID DIET; MALE; MOUSE; NITRERGIC NERVE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; TISSUE STRUCTURE;

ANIMALS; CYCLIC GMP; DIETARY FATS; IMPOTENCE, VASCULOGENIC; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; OBESITY; PENILE ERECTION; PENIS; RECEPTOR, ENDOTHELIN A;

EID: 79955413407     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09704.x     Document Type: Article

References (43)

1. Burnett AL, Lowenstein CJ, Bredt DS, et al,. Nitric oxide: a physiologic mediator of penile erection. Science 1992; 17: 401-3
2. Dean RC, Lue TF,. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am 2005; 32: 379-95 (Pubitemid 41607527)
3. Andersson KE,. Pharmacology of penile erection. Pharmacol Rev 2001; 53: 417-50
4. Lewis RW, Fugl-Meyer KS, Bosch R, et al,. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004; 1: 35-9 (Pubitemid 40424664)
5. Blumentals WA, Gomez-Caminero A, Joo S, et al,. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res 2004; 16: 350-3 (Pubitemid 39273762)
6. Kaya C, Uslu Z, Karaman I,. Is endothelial function impaired in erectile dysfunction patients? Int J Impot Res 2006; 8: 55-60 (Pubitemid 43050962)
7. Traish AM, Abu-Zahra H, Guay AT,. The brain, the penis and steroid hormones: clinical correlates with endothelial dysfunction. Curr Pharm 2008; 14: 3723-36
8. Watts GF, Chew KK, Stuckey BG,. The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention. Nat Clin Pract Cardiovasc Med 2007; 4: 263-73 (Pubitemid 46672115)
9. Corona G, Mannucci E, Forti G, et al,. Hypogonadism ED, metabolic syndrome and obesity: A pathological link supporting cardiovascular diseases. Int J Androl 2009; 32: 587-98
10. Behr-Roussel D, Gorny D, Mevel K, et al,. Erectile dysfunction: an early marker for hypertension? A longitudinal study in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005; 288: R276-83 (Pubitemid 40023940)
11. Stepp DW,. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond. Clin Exp Pharmacol Physiol 2006; 33: 407-14
12. Segura J, Ruilope LM,. Obesity, essential hypertension and renin-angiotensin system. Public Health Nutr 2007; 10: 1151-5 (Pubitemid 350089882)
13. Kedzierski RM, Yanagisawa M,. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 2001; 41: 851-76 (Pubitemid 32385909)
14. Böhm F, Pernow J,. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 2007; 76: 8-18 (Pubitemid 47362047)
15. Tamler R,. Diabetes, obesity, and erectile dysfunction. Gend Med 2009; 6: 4-16
16. Esposito K, Giugliano F, Di Palo C, et al,. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291: 2978-84 (Pubitemid 38802687)
17. Esposito K, Giugliano F, De Sio M, et al,. Dietary factors in erectile dysfunction. Int J Impot Res 2006; 18: 370-4
18. Esposito K, Giugliano F, Ciotola M, et al,. Obesity and sexual dysfunction, male and female. Int J Impot Res 2008; 20: 358-65
19. Esposito K, Giugliano D,. Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res 2005; 17: 391-8 (Pubitemid 43093239)
20. Paravicini TM, Touyz RM,. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008; 31: S170-S180
21. Frisbee JC, Maier KG, Stepp DW,. Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats. Am J Physiol Heart Circ Physiol 2002; 283: H2160-8 (Pubitemid 35345915)
22. Stepp DW, Frisbee JC,. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 2002; 282: H816-20 (Pubitemid 34654915)
23. Oltman CL, Coppey LJ, Gellett JS, et al,. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J Physiol Endocrinol Metab 2005; 289: E113-22 (Pubitemid 40874942)
24. Carneiro FS, Giachini FR, Lima VV, et al,. Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse. J Sex Med 2008; 5: 1156-66 (Pubitemid 351618021)
25. Galgani J, Ravussin E,. Energy metabolism, fuel selection and body weight regulation. Int J Obes (Lond) 2008; 32: S109-S19
26. Surwit RS, Feinglos MN, Rodin J, et al,. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995; 44: 645-51
27. Ikemoto S, Takahashi M, Tsunoda N, et al,. High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism 1996; 45: 1539-46 (Pubitemid 26424584)
28. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al,. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007; 56: 1986-98 (Pubitemid 47195825)
29. Calixto MC, Lintomen L, Schenka A, et al,. Obesity enhances the eosinophilic inflammation in a murine allergic asthma model. Br J Pharmacol 2010; 159: 617-25
30. Teixeira CE, Priviero FB, Webb RC,. Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta. J Pharmacol Exp Ther 2006; 316: 654-61 (Pubitemid 43130992)
31. Xie D, Odronic SI, Wu F, et al,. A mouse model of hypercholesterolemia- induced erectile dysfunction. J Sex Med 2007; 4: 898-907 (Pubitemid 47079627)
32. Behr-Roussel D, Darblade B, Oudot A, et al,. Erectile dysfunction in hypercholesterolemic atherosclerotic apolipoprotein E knockout mice. J Sex Med 2006; 3: 596-603
33. Baumhäkel M, Custodis F, Schlimmer N, et al,. Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan. J Pharmacol Exp Ther 2008; 327: 692-8
34. Filippi S, Vignozzi L, Morelli A, et al,. Testosterone Partially Ameliorates Metabolic Profile and Erectile Responsiveness to PDE5 Inhibitors in an Animal Model of Male Metabolic Syndrome. J Sex Med 2009; 6: 3274-88
35. Rao DNR, Elguindi S, O'Brien PJ,. Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes. Arch Biochem Biophys 1991; 286: 30-7
36. Bates JN, Baker MT, Guerra R, et al,. Chemical release of nitric oxide from sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 1992; 262: 916-22
37. Ushiyama M, Kuramochi T, Yagi S, et al,. Antioxidant treatment with alpha-tocopherol improves erectile function in hypertensive rats. Hypertens Res 2008; 31: 1007-13 (Pubitemid 351895045)
38. phox Subunit of NAD(P)H oxidase contributes to erectile dysfunction caused by long-term nitric oxide inhibition in rats: Reversion by regular physical training. Urology 2010; 75: 961-7
39. Andersson KE, Stief CG,. Neurotransmission and the contraction and relaxation of penile erectile tissues. World J Urol 1997; 15: 14-20 (Pubitemid 127769830)
40. Vanhoutte PM,. Endothelial dysfunction and atherosclerosis. Eur Heart J 1997; 18 (Suppl. E): E19-29
41. Okon EB, Szado T, Laher I, et al,. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 2003; 40: 520-30 (Pubitemid 38186462)
42. Mather KJ, Lteif A, Steinberg HO, et al,. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes 2004; 53: 2060-6 (Pubitemid 38970755)
43. Mumtaz FH, Lau DH, Siddiqui EJ, et al. Pharmacological properties of endothelin-1 in the rabbit corpus cavernosum. In Vivo 2006; 20: 243-6